Status: current, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3758942014 | Ravulizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3758943016 | Ravulizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ravulizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Ravulizumab | Is a | Complement 5 inhibitor | true | Inferred relationship | Some | ||
| Ravulizumab | Has disposition | Complement 5 inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ravulizumab-containing product | Has active ingredient | True | Ravulizumab | Inferred relationship | Some | 1 |
| Ravulizumab only product | Has active ingredient | True | Ravulizumab | Inferred relationship | Some | 1 |
| Ravulizumab-containing product in parenteral dose form | Has active ingredient | True | Ravulizumab | Inferred relationship | Some | 1 |
| Ravulizumab only product in parenteral dose form | Has active ingredient | True | Ravulizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR